LONDON, UK – Central and Eastern European entrepreneurs are securing major investment rounds totaling over $50 million in 2024-2025 to revolutionize intimate wellness through breakthrough technologies that address period pain, erectile dysfunction, and modern relationship challenges. These companies represent a new generation of health technology startups, often called “sextech” or “femtech”, that use digital solutions, artificial intelligence, and medical research to solve problems that traditional healthcare has overlooked for decades.
The investment surge follows a historic milestone when Lisbon-based sexual wellness startup Pleasy Play became the first sextech company to win the CEE-based Wolves Summit pitch contest in 2021, marking a turning point for investor acceptance in this previously taboo sector. Venture capital firms (investment companies that fund startups) and healthcare investors are now recognizing that intimate wellness represents a massive market opportunity, with the global sexual wellness market expected to reach $120 billion by 2030.
Leading the funding wave is Munich-based Kranus Health, which raised $20 million total funding including a recent $5 million Series A extension led by CapHorn and Future Positive Capital. The company, co-founded by Bulgarian engineer Nikolay Dimolarov, has developed the world’s first government-approved digital therapy for erectile dysfunction (a medical condition affecting sexual function) that patients can receive free through their health insurance.
Revolutionary Period Pain Solutions Gain Momentum
Bulgarian founder Valentina Milanova’s London-based company Daye has raised nearly $24 million in Series A funding to commercialize CBD-infused tampons and diagnostic testing technology that screens for sexually transmitted infections from home. In 2024, Daye’s diagnostic tampon was recognized by TIME magazine as one of the greatest inventions of the year, highlighting how products once considered taboo are now viewed as serious medical innovations.
“By researching and going deeper into the topic of female healthcare, I realized how monopolized the tampon industry is,” Milanova explained in a recent interview, noting the lack of clinical trials for vaginal health products and testing on how different products affect the vaginal microbiome (the community of bacteria and other microorganisms that naturally live in the vagina). Clinical trials are rigorous scientific studies that test whether medical treatments are safe and effective before they can be sold to patients.
Research shows that 84% of college-aged women report pain during menstruation, with 43.1% experiencing pain during every cycle, yet traditional treatments have remained largely unchanged for decades. Daye’s approach combines cannabidiol (CBD), a non-psychoactive compound derived from hemp plants, with advanced diagnostic capabilities that can detect infections and human papillomavirus (HPV) using the same tampon.
Digital Dating Apps Challenge Traditional Romance
Bulgarian-founded Feeld, now based in New York, has grown to over 2 million members globally while pioneering a new approach to dating that accommodates non-traditional relationships including polyamory (having multiple romantic partners with everyone’s knowledge and consent) and ethical non-monogamy. The company reported 30% year-over-year growth globally since 2022 and recently launched “A Fucking Magazine” to create cultural content around modern relationships.
A recent comprehensive study by Feeld examining over 6,000 respondents across the U.S., U.K., and Netherlands found that 83% of transgender, nonbinary, and genderqueer respondents prefer online dating over offline interactions, primarily citing safety concerns. This research, conducted in collaboration with Dr. Apryl Williams from the University of Michigan, demonstrates how digital platforms can create safer spaces for marginalized communities to explore romantic connections.
Originally launched as “3nder” in 2014, the app was forced to rebrand after facing legal challenges from Tinder’s parent company Match Group, but has since established itself as a legitimate alternative in the dating app ecosystem. Unlike traditional dating apps that focus on finding “the one,” Feeld encourages users to explore their desires and connect with like-minded individuals whether they’re single or in relationships.
Men’s Health Startups Break Medical Taboos
Kranus Health, co-founded by 29-year-old Bulgarian CTO Nikolay Dimolarov, has treated over 10,000 patients with its digital erectile dysfunction therapy and works with more than 1,000 prescribing urologists across Germany and France. The company’s Kranus Edera app provides a 12-week therapy program including pelvic floor training, cardiovascular exercises, and mindfulness techniques, with clinical trials showing significant improvement in erectile function and quality of life.
“At Kranus Health, we break taboos and solve men’s health issues that no one talks about,” explained co-founder Thilo Kleinschmidt, highlighting that erectile dysfunction affects every third male, while incontinence impacts 20% of men over 60, and prostate enlargement affects every second man over 50. Digital therapeutics (evidence-based software programs designed to treat medical conditions) represent a new category of treatment that can be prescribed by doctors and reimbursed by insurance companies, just like traditional medications.
The company’s recent funding success positions it as one of the best-funded virtual care companies in Europe, with plans to expand internationally and develop treatments for prostate cancer, making it a comprehensive platform for men’s urological health. Urology is the medical specialty that focuses on diseases of the urinary system and male reproductive organs.
Market Transformation Signals Broader Change
Industry analysts project the global sextech market will grow from $42.59 billion in 2024 to $107.85 billion by 2030, representing a compound annual growth rate of 16.7%, driven by increasing attention to sexual health and the integration of advanced technologies like artificial intelligence and virtual reality. Compound annual growth rate (CAGR) is a financial metric that shows how much an industry grows each year on average over a specific period.
Despite this growth potential, securing funding remains challenging due to social taboos and advertising restrictions on major platforms, with many venture capital firms having policies that prohibit investments in sexual wellness companies. However, specialized accelerators focusing on sextech and individual investors are creating new funding pathways, indicating a fundamental shift in societal attitudes toward sexual health and wellness.
The success of CEE startups in this space demonstrates how entrepreneurs from emerging markets can leverage their unique perspectives and technical expertise to address global health challenges that established markets have ignored. These companies are not only creating innovative products but also contributing to important conversations about sexual health education and breaking down barriers that have prevented people from accessing appropriate medical care.
This analysis is based on funding data from Dealroom, company reports, and clinical studies conducted between 2022-2025 across Central and Eastern European markets including Bulgaria, Germany, and the United Kingdom. The research encompasses companies that have raised significant venture capital funding and achieved regulatory approval for their medical devices and digital therapeutics.
Key Takeaways
- CEE startups raised over $50 million in 2024-2025 developing digital solutions for period pain, erectile dysfunction, and modern dating challenges.
- Despite massive market potential reaching $107 billion by 2030, sextech companies still face funding barriers due to social taboos and advertising restrictions.
- Bulgarian and other CEE entrepreneurs are leading breakthrough innovations in intimate wellness, combining medical research with advanced technology for better health outcomes.
Keep Reading
- Ultimate List of Global Health Tech Investment Opportunities – Discover emerging markets and funding trends worldwide including Central European digital health innovation ecosystems
- How Sextech Startups Overcome Investment Challenges – Learn proven strategies for securing venture capital despite industry taboos and regulatory hurdles
- The Beginner’s Guide to App-Based Digital Therapeutics and Medicine – Understand how software programs are becoming prescribed treatments with insurance coverage and clinical validation
- $60B FemTech Industry Growth and Investment Opportunities – Our team explored the market data and investment opportunities in women’s health technology
- Best Period Tracking and Pain Management Apps for 2025 – We compare top-rated menstrual health apps and discover new technologies for period pain relief
